Advertisement

Biophysical Reviews

, Volume 9, Issue 2, pp 139–148 | Cite as

The melatonin immunomodulatory actions in radiotherapy

  • M. Najafi
  • A. ShiraziEmail author
  • E. MotevaseliEmail author
  • Gh. Geraily
  • F. Norouzi
  • M. Heidari
  • S. Rezapoor
Review

Abstract

Radiotherapy has a key role in cancer treatment in more than half of patients with cancer. The management of severe side effects of this treatment modality is a limiting factor to appropriate treatment. Immune system responses play a pivotal role in many of the early and late side effects of radiation. Moreover, immune cells have a significant role in tumor response to radiotherapy, such as angiogenesis and tumor growth. Melatonin as a potent antioxidant has shown appropriate immune regulatory properties that may ameliorate toxicity induced by radiation in various organs. These effects are mediated through various modulatory effects of melatonin in different levels of tissue reaction to ionizing radiation. The effects on the DNA repair system, antioxidant enzymes, immune cells, cytokines secretion, transcription factors, and protein kinases are most important. Moreover, anti-cancer properties of melatonin may increase the therapeutic ratio of radiotherapy. Clinical applications of this agent for the management of malignancies such as breast cancer have shown promising results. It seems anti-proliferative, anti-angiogenesis, and stimulation or suppression of some immune cell responses are the main anti-tumor effects of melatonin that may help to improve response of the tumor to radiotherapy. In this review, the effects of melatonin on the modulation of immune responses in both normal and tumor tissues will be discussed.

Keywords

Melatonin Radiation Immune system Radiotherapy Cancer 

Notes

Acknowledgments

Tehran University of Medical Sciences grant number 33480.

Compliance with ethical standards

Conflict of interest

M. Najafi declares that he has no conflict of interest. A. Shirazi declares that he has no conflict of interest. E. Motevaseli declares that she has no conflict of interest. Gh. Geraily declares that she has no conflict of interest. F. Norouzi declares that he has no conflict of interest. M. Heidari declares that he has no conflict of interest. S Rezapoor declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. Amundson SA (2008) Functional genomics and a new era in radiation biology and oncology. Bioscience 58(6):491–500PubMedPubMedCentralCrossRefGoogle Scholar
  2. Aydogan S, Yerer MB, Goktas A (2006) Melatonin and nitric oxide. J Endocrinol Investig 29(3):281–287CrossRefGoogle Scholar
  3. Behr TM, Sgouros G, Stabin MG, Béhé M, Angerstein C, Blumenthal RD et al (1999) Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with β-, Auger/conversion electron-, or α-emitters. Clin Cancer Res 5(10):3031s–3043sPubMedGoogle Scholar
  4. Bentzen SM (2006) Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6(9):702–713PubMedCrossRefGoogle Scholar
  5. Bondy SC, Lahiri DK, Perreau VM, Sharman KZ, Campbell A, Zhou J et al (2004) Retardation of brain aging by chronic treatment with melatonin. Ann N Y Acad Sci 1035(1):197–215PubMedCrossRefGoogle Scholar
  6. Bower JE, Ganz PA, Aziz N, Fahey JL (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64(4):604–611PubMedCrossRefGoogle Scholar
  7. Bower JE, Ganz PA, Tao ML, Hu W, Belin TR, Sepah S et al (2009) Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res 15(17):5534–5540PubMedPubMedCentralCrossRefGoogle Scholar
  8. Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, McBride WH (eds) (2007) Molecular mechanisms of late normal tissue injury. Seminars in radiation oncology. ElsevierGoogle Scholar
  9. Caballero B, Vega‐Naredo I, Sierra V, Huidobro‐Fernández C, Soria‐Valles C, Gonzalo‐Calvo D et al (2009) Melatonin alters cell death processes in response to age‐related oxidative stress in the brain of senescence‐accelerated mice. J Pineal Res 46(1):106–114PubMedCrossRefGoogle Scholar
  10. Cagnoli CM, Atabay C, Kharlamova E, Manev H (1995) Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 18(4):222–226PubMedCrossRefGoogle Scholar
  11. Cakmak Karaer I, Simsek G, Yildiz A, Vardi N, Polat A, Tanbek K et al (2016) Melatonin’s protective effect on the salivary gland against ionized radiation damage in rats. J Oral Pathol Med 45(6):444–449PubMedCrossRefGoogle Scholar
  12. Calveley VL, Khan MA, Yeung IW, Vandyk J, Hill RP (2005) Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation. Int J Radiat Biol 81(12):887–899PubMedCrossRefGoogle Scholar
  13. Canyilmaz E, Uslu GH, Bahat Z, Kandaz M, Mungan S, Haciislamoglu E et al (2016) Comparison of the effects of melatonin and genistein on radiation-induced nephrotoxicity: Results of an experimental study. Biomed Rep 4(1):45–50PubMedGoogle Scholar
  14. Carrillo-Vico A, Reiter RJ, Lardone PJ, Herrera JL, Fernández-Montesinos R, Guerrero JM et al (2006) The modulatory role of melatonin on immune responsiveness. Curr Opin Investig Drugs 7(5):423PubMedGoogle Scholar
  15. Chávez E, Reyes‐Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P et al (2008) Resveratrol prevents fibrosis, NF‐κB activation and TGF‐β increases induced by chronic CCl4 treatment in rats. J Appl Toxicol 28(1):35–43PubMedCrossRefGoogle Scholar
  16. Chetsawang B, Putthaprasart C, Phansuwan-Pujito P, Govitrapong P (2006) Melatonin protects against hydrogen peroxide-induced cell death signaling in SH-SY5Y cultured cells: involvement of nuclear factor kappa B, Bax and Bcl-2. J Pineal Res 41(2):116–123PubMedCrossRefGoogle Scholar
  17. Cho SY, Lee HJ, Jeong SJ, Lee HJ, Kim HS, Chen CY et al (2011) Sphingosine kinase 1 pathway is involved in melatonin‐induced HIF‐1α inactivation in hypoxic PC‐3 prostate cancer cells. J Pineal Res 51(1):87–93PubMedCrossRefGoogle Scholar
  18. Choi YW, Munden RF, Erasmus JJ, Joo Park K, Chung WK, Jeon SC et al (2004) Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis 1. Radiographics 24(4):985–997PubMedCrossRefGoogle Scholar
  19. Choi EY, Jin JY, Lee JY, Choi JI, Choi IS, Kim SJ (2011) Melatonin inhibits Prevotella intermedia lipopolysaccharide‐induced production of nitric oxide and interleukin‐6 in murine macrophages by suppressing NF‐κB and STAT1 activity. J Pineal Res 50(2):197–206PubMedGoogle Scholar
  20. Christopher FL, Dussault I, Miller SC (1991) Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2. Immunobiology 184(1):37–52PubMedCrossRefGoogle Scholar
  21. Cos S, Blask DE (1994) Melatonin modulates growth factor activity in MCF‐7 human breast cancer cells. J Pineal Res 17(1):25–32PubMedCrossRefGoogle Scholar
  22. Cucina A, Proietti S, D’Anselmi F, Coluccia P, Dinicola S, Frati L et al (2009) Evidence for a biphasic apoptotic pathway induced by melatonin in MCF‐7 breast cancer cells. J Pineal Res 46(2):172–180PubMedCrossRefGoogle Scholar
  23. Currier NL, Miller SC (2001) Echinacea purpurea and melatonin augment natural-killer cells in leukemic mice and prolong life span. J Altern Complement Med (New York, NY) 7(3):241–251CrossRefGoogle Scholar
  24. Currier NL, Sun L-Y, Miller SC (2000) Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity. J Neuroimmunol 104(2):101–108PubMedCrossRefGoogle Scholar
  25. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabo C (1997) Protective effect of melatonin in carrageenan‐induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J Pineal Res 23(2):106–116PubMedCrossRefGoogle Scholar
  26. Cuzzocrea S, Costantino G, Mazzon E, Caputi AP (1999) Regulation of prostaglandin production in carrageenan‐induced pleurisy melatonin. J Pineal Res 27(1):9–14PubMedCrossRefGoogle Scholar
  27. Deng W-G, Tang S-T, Tseng H-P, Wu KK (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108(2):518–524PubMedPubMedCentralCrossRefGoogle Scholar
  28. Di Bella G, Mascia F, Gualano L, Di Bella L (2013) Melatonin anticancer effects: review. Int J Mol Sci 14(2):2410–2430PubMedPubMedCentralCrossRefGoogle Scholar
  29. Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C et al (2015) Portrait of inflammatory response to ionizing radiation treatment. J Inflamm 12(1):14CrossRefGoogle Scholar
  30. Dragicevic N, Copes N, O’Neal‐Moffitt G, Jin J, Buzzeo R, Mamcarz M et al (2011) Melatonin treatment restores mitochondrial function in Alzheimer’s mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 51(1):75–86PubMedCrossRefGoogle Scholar
  31. Emerit I, Oganesian N, Sarkisian T, Arutyunyan R, Pogosian A, Asrian K et al (1995) Clastogenic factors in the plasma of Chernobyl accident recovery workers: anticlastogenic effect of Ginkgo biloba extract. Radiat Res 144(2):198–205PubMedCrossRefGoogle Scholar
  32. Fardid R, Salajegheh A, Mosleh-Shirazi MA, Sharifzadeh S, Okhovat MA, Najafi M, Rezaeyan A, Abaszadeh A (2017) Melatonin ameliorates the production of COX-2, iNOS, and the formation of 8-OHdG in non-targeted lung tissue after pelvic irradiation. Cell J 19(2):324-331. doi: 10.22074/cellj.2016.3857
  33. García JA, Volt H, Venegas C, Doerrier C, Escames G, López LC et al (2015) Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice. FASEB J 29(9):3863–3875PubMedCrossRefGoogle Scholar
  34. Garcia-Maurino S, Gonzalez-Haba MG, Calvo JR, Rafii-El-Idrissi M, Sanchez-Margalet V, Goberna R et al (1997) Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol 159(2):574–581PubMedGoogle Scholar
  35. García‐Mauriño S, Pozo D, Calvo JR, Guerrero JM (2000) Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J Pineal Res 29(3):129–137PubMedCrossRefGoogle Scholar
  36. Garcı́a-Pergañeda A, Guerrero JM, Rafii-El-Idrissi M, Romero MP, Pozo D, Calvo JR (1999) Characterization of membrane melatonin receptor in mouse peritoneal macrophages: inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein. J Neuroimmunol 95(1):85–94PubMedCrossRefGoogle Scholar
  37. Golden EB, Apetoh L (eds) (2015) Radiotherapy and immunogenic cell death. Seminars in radiation oncology. ElsevierGoogle Scholar
  38. Golden E, Pellicciotta I, Demaria S, Barcellos-Hoff MH, Formenti SC (2012) The convergence of radiation and immunogenic cell death signaling pathways. Front Oncol 2:88PubMedPubMedCentralCrossRefGoogle Scholar
  39. Green DR, Ferguson T, Zitvogel L, Kroemer G (2009) Immunogenic and tolerogenic cell death. Nat Rev Immunol 9(5):353–363PubMedPubMedCentralCrossRefGoogle Scholar
  40. Gürses İ, Özeren M, Serin M, Yücel N, Erkal HŞ (2014) Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. Pathol Res Pract 210(12):863–871PubMedCrossRefGoogle Scholar
  41. Haddadi GH, Shirazi AR, Sepehrizadeh Z, Mahdavi SR, Haddadi M (2013) Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats. Cell J 14(4):246–253PubMedPubMedCentralGoogle Scholar
  42. Harris JW, Phillips TL (1971) Radiobiological and biochemical studies of thiophosphate radioprotective compounds related to cysteamine. Radiat Res 46(2):362–379PubMedCrossRefGoogle Scholar
  43. Hashimoto S, Shirato H, Hosokawa M, Nishioka T, Kuramitsu Y, Matushita K et al (1999) The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats. Radiat Res 151(6):717–724PubMedCrossRefGoogle Scholar
  44. Hayashi T, Morishita Y, Kubo Y, Kusunoki Y, Hayashi I, Kasagi F et al (2005) Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am J Med 118(1):83–86PubMedCrossRefGoogle Scholar
  45. Haddadi GH, Rezaeyan A, Mosleh-Shirazi MA, Hosseinzadeh M, Fardid R, Najafi M, et al (2017) Hesperidin as radioprotector against radiation-induced lung damage in rat: A histopathological study. J Med Phys 42:25–32Google Scholar
  46. Heylmann D, Rödel F, Kindler T, Kaina B (2014) Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells. Biochim Biophys Acta Rev Cancer 1846(1):121–129CrossRefGoogle Scholar
  47. Hong Y, Won J, Lee Y, Lee S, Park K, Chang KT et al (2014) Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells. J Pineal Res 56(3):264–274PubMedCrossRefGoogle Scholar
  48. Jang SS, Kim HG, Lee JS, Han JM, Park HJ, Huh GJ et al (2013) Melatonin reduces X-ray radiation-induced lung injury in mice by modulating oxidative stress and cytokine expression. Int J Radiat Biol 89(2):97–105PubMedCrossRefGoogle Scholar
  49. Jardim BV, Ferreira LC, Borin TF, Moschetta MG, Gelaleti GB, Lopes JR et al (eds) (2013) Evaluation of the anti-angiogenic action of melatonin in breast cancer. BMC Proceedings, BioMed CentralGoogle Scholar
  50. Jardim-Perassi BV, Arbab AS, Ferreira LC, Borin TF, Varma NR, Iskander AS et al (2014) Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer. PLoS One 9(1):e85311PubMedPubMedCentralCrossRefGoogle Scholar
  51. Joo SS, Yoo YM (2009) Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res 47(1):8–14PubMedCrossRefGoogle Scholar
  52. Kang JW, Lee SM (2012) Melatonin inhibits type 1 interferon signaling of toll‐like receptor 4 via heme oxygenase‐1 induction in hepatic ischemia/reperfusion. J Pineal Res 53(1):67–76PubMedCrossRefGoogle Scholar
  53. Karslioğlu I, Ertekin MV, Taysi S, Koçer I, Sezen O, Gepdiremen A et al (2005) Radioprotective effects of melatonin on radiation-induced cataract. J Radiat Res 46(2):277–282PubMedCrossRefGoogle Scholar
  54. Kaur C, Ling EA (1999) Effects of melatonin on macrophages/microglia in postnatal rat brain. J Pineal Res 26(3):158–168PubMedCrossRefGoogle Scholar
  55. Kiefer W, Dannhardt G (2002) COX-2 inhibition and the control of pain. Curr Opin Investig Drugs (London, England: 2000) 3(9):1348–1358Google Scholar
  56. Kireev RA, Tresguerres AC, Castillo C, Salazar V, Ariznavarreta C, Vara E et al (2007) Effect of exogenous administration of melatonin and growth hormone on pro‐antioxidant functions of the liver in aging male rats. J Pineal Res 42(1):64–70PubMedCrossRefGoogle Scholar
  57. Kleszczyński K, Zillikens D, Fischer TW (2016) Melatonin enhances mitochondrial ATP synthesis, reduces reactive oxygen species formation, and mediates translocation of the nuclear erythroid 2‐related factor 2 resulting in activation of phase‐2 antioxidant enzymes (γ‐GCS, HO‐1, NQO1) in ultraviolet radiation‐treated normal human epidermal keratinocytes (NHEK). J Pineal Res 61(2):187–197PubMedCrossRefGoogle Scholar
  58. Kohchi C, Inagawa H, Nishizawa T, Soma G-I (2009) ROS and innate immunity. Anticancer Res 29(3):817–821PubMedGoogle Scholar
  59. Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan D-X (2009) Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 15(1–2):43–50PubMedGoogle Scholar
  60. Kotler M, Rodríguez C, Sáinz RM, Antolin I, Menéndez‐Peláez A (1998) Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 24(2):83–89PubMedCrossRefGoogle Scholar
  61. Kusunoki Y, Hayashi T (2008) Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors. Int J Radiat Biol 84(1):1–14PubMedCrossRefGoogle Scholar
  62. Kusunoki Y, Yamaoka M, Kubo Y, Hayashi T, Kasagi F, Douple EB et al (2010) T-cell immunosenescence and inflammatory response in atomic bomb survivors. Radiat Res 174(6b):870–876PubMedCrossRefGoogle Scholar
  63. Leach JK, Van Tuyle G, Lin P-S, Schmidt-Ullrich R, Mikkelsen RB (2001) Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res 61(10):3894–3901PubMedGoogle Scholar
  64. León J, Casado J, Jiménez Ruiz SM, Zurita MS, González‐Puga C, Rejón JD et al (2014) Melatonin reduces endothelin‐1 expression and secretion in colon cancer cells through the inactivation of FoxO‐1 and NF‐κβ. J Pineal Res 56(4):415–426PubMedCrossRefGoogle Scholar
  65. Lezoualc’h F, Sparapani M, Behl C (1998) N‐acetyl‐serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF‐κB. J Pineal Res 24(3):168–178PubMedCrossRefGoogle Scholar
  66. Li W, Fan M, Chen Y, Zhao Q, Song C, Yan Y et al (2015) Melatonin induces cell apoptosis in AGS cells through the activation of JNK and P38 MAPK and the suppression of nuclear factor-kappa B: a novel therapeutic implication for gastric cancer. Cell Physiol Biochem 37(6):2323–2338PubMedCrossRefGoogle Scholar
  67. Linard C, Marquette C, Mathieu J, Pennequin A, Clarençon D, Mathé D (2004) Acute induction of inflammatory cytokine expression after γ-irradiation in the rat: effect of an NF-κB inhibitor. Int J Radiat Oncol Biol Phys 58(2):427–434PubMedCrossRefGoogle Scholar
  68. Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ (2001) Anti-angiogenic activity of melatonin in advanced cancer patients. Neuroendocrinol Lett 22(1):45–48PubMedGoogle Scholar
  69. Liu H, Xu L, Wei JE, Xie MR, Wang SE, Zhou RX (2011) Role of CD4+ CD25+ regulatory T cells in melatonin‐mediated inhibition of murine gastric cancer cell growth in vivo and in vitro. Anat Rec 294(5):781–788CrossRefGoogle Scholar
  70. Lorimore SA, Coates PJ, Scobie GE, Milne G, Wright EG (2001) Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? Oncogene 20(48):7085–7095PubMedCrossRefGoogle Scholar
  71. Luchetti F, Betti M, Canonico B, Arcangeletti M, Ferri P, Galli F et al (2009) ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells. Free Radic Biol Med 46(3):339–351PubMedCrossRefGoogle Scholar
  72. Maestroni GJ (1995) T‐Helper‐2 lymphocytes as a peripheral target of melatonin. J Pineal Res 18(2):84–89PubMedCrossRefGoogle Scholar
  73. Manchester LC, Coto‐Montes A, Boga JA, Andersen LPH, Zhou Z, Galano A et al (2015) Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res 59(4):403–419PubMedCrossRefGoogle Scholar
  74. Mayo JC, Sainz RM, Tan D-X, Hardeland R, Leon J, Rodriguez C et al (2005) Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 165(1):139–149PubMedCrossRefGoogle Scholar
  75. Meltz ML, Reiter RJ, Herman TS (1999) Melatonin and protection from genetic damage in blood and bone marrow: Whole‐body irradiation studies in mice. J Pineal Res 27(4):221–225PubMedCrossRefGoogle Scholar
  76. Michaeloudes C, Sukkar MB, Khorasani NM, Bhavsar PK, Chung KF (2011) TGF-β regulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells. Am J Phys Lung Cell Mol Phys 300(2):L295–L304Google Scholar
  77. Mihandoust E, Shirazi A (2010) Application of radioprotective agents in cancer treatment. Iran J Nucl Med 18(1):107–107Google Scholar
  78. Mohan N, Sadeghi K, Reiter RJ, Meltz ML (1995) The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem Mol Biol Int 37(6):1063–1070PubMedGoogle Scholar
  79. Muralidharan S, Mandrekar P (2013) Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol 94(6):1167–1184PubMedPubMedCentralCrossRefGoogle Scholar
  80. Najafi M, Fardid R, Hadadi Gh, Fardid M (2014) The Mechanisms of Radiation-Induced Bystander Effect. J Biomed Phys Eng 4(4):163-172.Google Scholar
  81. Najafi M, Fardid R, Takhshid MA, Mosleh-Shirazi MA, Rezaeyan AH, Salajegheh A (2016) Radiation-induced oxidative stress at out-of-field lung tissues after pelvis irradiation in rats. Cell J 18(3):340–345PubMedPubMedCentralGoogle Scholar
  82. Najafi M, Salajegheh A, Rezaeyan A (2017a) Bystander effect and second primary cancers following radiotherapy: What are its significances?. J Med Phys 42:55–56Google Scholar
  83. Najafi M, Shirazi A, Motevaseli E, Rezaeyan AH, Salajegheh A, Rezapoor S (2017b) Melatonin as an anti-inflammatory agent in radiotherapy. Inflammopharmacology. doi: 10.1007/s10787-017-0332-5
  84. Ortiz F, Acuña‐Castroviejo D, Doerrier C, Dayoub JC, López LC, Venegas C et al (2015) Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation‐induced oral mucositis. J Pineal Res 58(1):34–49PubMedCrossRefGoogle Scholar
  85. Park SY, Jang WJ, Yi EY, Jang JY, Jung Y, Jeong JW et al (2010) Melatonin suppresses tumor angiogenesis by inhibiting HIF‐1α stabilization under hypoxia. J Pineal Res 48(2):178–184PubMedCrossRefGoogle Scholar
  86. Perrone G, Ruffini PA, Catalano V, Spino C, Santini D, Muretto P et al (2008) Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer (Oxford, England : 1990) 44(13):1875–1882CrossRefGoogle Scholar
  87. Persson HL, Kurz T, Eaton JW, Brunk UT (2005) Radiation-induced cell death: importance of lysosomal destabilization. Biochem J 389(3):877–884PubMedPubMedCentralCrossRefGoogle Scholar
  88. Pockley AG (2012) Radiation-induced effects and the immune system in cancer. Radiat Induc Eff Immune Syst. 121Google Scholar
  89. Poon AM, Liu ZM, Pang CS, Brown GM, Pang SF (1994) Evidence for a direct action of melatonin on the immune system. Biol Signals 3(2):107–117PubMedCrossRefGoogle Scholar
  90. Pozo D, Reiter RJ, Calvo JR, Guerrero JM (1994) Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 55(24):PL455–PL460PubMedCrossRefGoogle Scholar
  91. Pozo DA, Delgado M, Fernandez-Santos JM, Calvo JR, Gomariz RP, Martin-Lacave I et al (1997) Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen. FASEB J 11(6):466–473PubMedGoogle Scholar
  92. Prise KM, O’Sullivan JM (2009) Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 9(5):351–360PubMedPubMedCentralCrossRefGoogle Scholar
  93. Raghavendra V, Singh V, Kulkarni SK, Agrewala JN (2001) Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem 221(1–2):57–62PubMedCrossRefGoogle Scholar
  94. Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18(49):6938–6947PubMedCrossRefGoogle Scholar
  95. Reiter RJ, Meltz ML (1995) Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat Res Lett 346(1):23–31CrossRefGoogle Scholar
  96. Reiter RJ, Tan D-X, Qi W-B (1998) Suppression of oxygen toxicity by melatonin. Acta Pharmacol Sin 19(6):575–581Google Scholar
  97. Reiter RJ, Tan D-X, Burkhardt S (2002) Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev 123(8):1007–1019PubMedCrossRefGoogle Scholar
  98. Reiter RJ, Rosales-Corral SA, Manchester LC, Tan D-X (2013a) Peripheral reproductive organ health and melatonin: ready for prime time. Int J Mol Sci 14(4):7231–7272PubMedPubMedCentralCrossRefGoogle Scholar
  99. Reiter RJ, Tan D-X, Galano A (2013b) Melatonin reduces lipid peroxidation and membrane viscosity. Front Physiol 5:377Google Scholar
  100. Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre‐Jimenez M, Qin L (2016) Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 61(3):253–278PubMedCrossRefGoogle Scholar
  101. Rezaeyan A, Fardid R, Haddadi GH, Takhshid MA, Hosseinzadeh M, Najafi M, Salajegheh A (2016a) Evaluating radioprotective effect of hesperidin on acute radiation damage in the lung tissue of rats. J Biomed Phys Eng 6(3):165–174PubMedPubMedCentralGoogle Scholar
  102. Rezaeyan A, Haddadi GH, Hosseinzadeh M, Moradi M, Najafi M (2016b) Radioprotective effects of hesperidin on oxidative damages and histopathological changes induced by X-irradiation in rats heart tissue. J Med Phys 41(3):182–191PubMedPubMedCentralCrossRefGoogle Scholar
  103. Rock KL, Lai JJ, Kono H (2011) Innate and adaptive immune responses to cell death. Immunol Rev 243(1):191–205PubMedPubMedCentralCrossRefGoogle Scholar
  104. Rodel F, Frey B, Gaipl U, Keilholz L, Fournier C, Manda K et al (2012) Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application. Curr Med Chem 19(12):1741–1750PubMedCrossRefGoogle Scholar
  105. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V et al (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36(1):1–9PubMedCrossRefGoogle Scholar
  106. Sainz RM, Reiter RJ, Tan DX, Roldan F, Natarajan M, Quiros I et al (2008) Critical role of glutathione in melatonin enhancement of tumor necrosis factor and ionizing radiation‐induced apoptosis in prostate cancer cells in vitro. J Pineal Res 45(3):258–270PubMedCrossRefGoogle Scholar
  107. Sánchez‐Hidalgo M, Lee M, de la Lastra CA, Guerrero JM, Packham G (2012) Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines. J Pineal Res 53(4):366–373PubMedCrossRefGoogle Scholar
  108. Sangiuliano B, Pérez NM, Moreira DF, Belizário JE (2014) Cell death-associated molecular-pattern molecules: inflammatory signaling and control. Mediat Inflamm 2014:821043CrossRefGoogle Scholar
  109. Schmuth M, Wimmer MA, Hofer S, Sztankay A, Weinlich G, Linder D et al (2002) Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double‐blind study. Br J Dermatol 146(6):983–991PubMedCrossRefGoogle Scholar
  110. Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJ et al (2011) Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther. 1534735411425484Google Scholar
  111. Şener G, Atasoy BM, Ersoy Y, Arbak S, Şengöz M, Yeğen BÇ (2004) Melatonin protects against ionizing radiation‐induced oxidative damage in corpus cavernosum and urinary bladder in rats. J Pineal Res 37(4):241–246PubMedCrossRefGoogle Scholar
  112. Serin M, Gülbaş H, Gürses İ, Erkal HŞ, Yücel N (2007) The histopathological evaluation of the effectiveness of melatonin as a protectant against acute lung injury induced by radiation therapy in a rat model. Int J Radiat Biol 83(3):187–193PubMedCrossRefGoogle Scholar
  113. Shi D, Xiao X, Wang J, Liu L, Chen W, Fu L et al (2012) Melatonin suppresses proinflammatory mediators in lipopolysaccharide‐stimulated CRL1999 cells via targeting MAPK, NF‐κB, c/EBPβ, and p300 signaling. J Pineal Res 53(2):154–165PubMedCrossRefGoogle Scholar
  114. Shirazi A, Ghobadi G, Ghazi-Khansari M (2007) A radiobiological review on melatonin: a novel radioprotector. J Radiat Res 48(4):263–272PubMedCrossRefGoogle Scholar
  115. Shirazi A, Mihandoost E, Mohseni M, Ghazi-Khansari M, Rabie Mahdavi S (2013) Radio-protective effects of melatonin against irradiation-induced oxidative damage in rat peripheral blood. Physica Medica 29(1):65–74PubMedCrossRefGoogle Scholar
  116. Somosy Z (2000) Radiation response of cell organelles. Micron 31(2):165–181PubMedCrossRefGoogle Scholar
  117. Szumiel I (2015) Ionizing radiation-induced oxidative stress, epigenetic changes and genomic instability: the pivotal role of mitochondria. Int J Radiat Biol 91(1):1–12PubMedCrossRefGoogle Scholar
  118. Tahamtan R, Monfared AS, Tahamtani Y, Tavassoli A, Akmali M, Mosleh-Shirazi MA et al (2015) Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats. Cell J 17(1):111–120PubMedPubMedCentralGoogle Scholar
  119. Tain Y-L, Chen C-C, Lee C-T, Kao Y-H, Sheen J-M, Yu H-R et al (2013) Melatonin regulates L-arginine transport and NADPH oxidase in young rats with bile duct ligation: role of protein kinase C. Pediatr Res 73(4–1):395–401PubMedCrossRefGoogle Scholar
  120. Tan D-X, Manchester LC, Reiter RJ, Qi W-B, Karbownik M, Calvo JR (2000) Significance of melatonin in antioxidative defense system: reactions and products. Neurosignals 9(3–4):137–159CrossRefGoogle Scholar
  121. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ (2007) One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42(1):28–42PubMedCrossRefGoogle Scholar
  122. Venegas C, García JA, Escames G, Ortiz F, López A, Doerrier C et al (2012) Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 52(2):217–227PubMedCrossRefGoogle Scholar
  123. Wu ZH, Miyamoto S (2007) Many faces of NF-kappaB signaling induced by genotoxic stress. J Mol Med (Berlin, Germany) 85(11):1187–1202CrossRefGoogle Scholar
  124. Wu CC, Lu KC, Lin GJ, Hsieh HY, Chu P, Lin SH et al (2012) Melatonin enhances endogenous heme oxygenase‐1 and represses immune responses to ameliorate experimental murine membranous nephropathy. J Pineal Res 52(4):460–469PubMedCrossRefGoogle Scholar
  125. Wu KK, Cheng H-H, Chang T-C (2014) 5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesis. J Biomed Sci 21(1):17PubMedPubMedCentralCrossRefGoogle Scholar
  126. Yu Q, Miller SC, Osmond DG (2000) Melatonin inhibits apoptosis during early B‐cell development in mouse bone marrow. J Pineal Res 29(2):86–93PubMedCrossRefGoogle Scholar
  127. Zhang HM, Zhang Y, Zhang BX (2011) The role of mitochondrial complex III in melatonin‐induced ROS production in cultured mesangial cells. J Pineal Res 50(1):78–82PubMedCrossRefGoogle Scholar
  128. Zhao W, Robbins ME (2009) Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 16(2):130–143PubMedCrossRefGoogle Scholar
  129. Zhou D, Yu T, Chen G, Brown SA, Yu Z, Mattson M et al (2001) Effects of NF-κB1 (p50) targeted gene disruption on ionizing radiation-induced NF-κB activation and TNFα, IL-1α, IL-1β and IL-6 mRNA expression in vivo. Int J Radiat Biol 77(7):763–772PubMedCrossRefGoogle Scholar
  130. Zhou R, Wang R, Song J, Zhang H, Luo J, Liu H (2015) Melatonin inhibit the angiogenesis of gastric cancer by nuclear receptor. FASEB J 29(1 Supplement):639.5Google Scholar

Copyright information

© International Union for Pure and Applied Biophysics (IUPAB) and Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Department of Medical Physics and Biomedical Engineering, Faculty of MedicineTehran University of Medical SciencesTehranIran
  2. 2.Department of Molecular Medicine, School of Advanced Technologies in MedicineTehran University of Medical SciencesTehranIran
  3. 3.Department of Medical Radiation Engineering, Science and Research BranchIslamic Azad UniversityTehranIran
  4. 4.Department of Radiology, Faculty of ParamedicalTehran University of Medical SciencesTehranIran

Personalised recommendations